Journey Medical DERM
NASDAQ DERM
$4.52 +0.05 (+1.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Journey Medical (DERM) Price to FCF (2023 - 2024)

Updated

Journey Medical's Price to FCF came in at 61.77 for Q1 2024, down 85.9% from the prior quarter.

Analysis

Journey Medical (DERM) Price to FCF (2023 - 2024) Analysis & Trends

For FY2023, Journey Medical's Price to FCF was 437.58.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Journey Medical 123.72 Mn 21.81 Mn 12.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 61.77
Dec 31, 2023 437.58
Sep 30, 2023 3.90
API Access

Journey Medical Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=DERM&period=max&api_key=YOUR_API_KEY